CLDX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Celldex Therapeutics (CLDX) Earnings Date & Reports

Industry: @Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

CLDX is expected to report earnings to rise 8.14% to -69 cents per share on March 03

Celldex Therapeutics CLDX Stock Earnings Reports

Q4'24

Est.

$-0.69

Q3'24

Beat

by $0.03

Q2'24

Beat

by $0.05

Q1'24

Beat

by $0.15

Q4'23

Missed

by $0.07

The last earnings report on November 06 showed earnings per share of -63 cents, beating the estimate of -67 cents. With 866.48K shares outstanding, the current market capitalization sits at 1.71B.

View a ticker or compare two or three

Compare

CLDX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For CLDX
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for CLDX (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a developer of immunotherapy technologies for the treatment of cancer and other diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

53 Frontage Road

Phone

+1 908 200-7500

Employees

160

Web

https://www.celldex.com